8 Notable Companies Making Strides in Decentralized Clinical Trials

by Bohdana Sokolova    Contributor        Biopharma insight

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   69    Comments 0

The world of clinical trials is undergoing a paradigm shift as the rise of decentralized clinical trials (DCTs) revolutionizes the way researchers conduct studies. With innovative technologies and novel approaches to trial management, a new breed of trailblazers is paving the way for the future of clinical research. In this blog article, we'll explore eight companies making waves in the DCT landscape, showcasing the remarkable progress they've made in recent years. From blockchain-powered data management to AI-driven patient recruitment, these cutting-edge organizations are breaking down traditional barriers and empowering patients to participate in trials with greater ease, flexibility, and convenience.

The space is dominated by large contract research players, like IQVIA, In this post, we will review eight relatively young companies enabling decentralized clinical trials. 


Deep 6 AI

Deep 6 AI is a health technology company founded in 2015, specializing in artificial intelligence (AI) solutions for decentralized clinical trials. Their platform focuses on patient recruitment, trial feasibility, and site selection by analyzing structured and unstructured real-world data from electronic health records (EHRs) and other sources.

Using natural language processing (NLP) and machine learning algorithms, Deep 6 AI's platform identifies eligible patients for clinical trials based on specific criteria such as demographics, medical history, and diagnoses. This helps researchers expedite the recruitment process, which is often a time-consuming and costly aspect of clinical trials.

The platform also assists in determining trial feasibility by providing insights into patient populations, ensuring trials are designed with realistic expectations. Additionally, Deep 6 AI's solution aids in selecting the most suitable trial sites, factoring in aspects like patient availability, site performance, and investigator experience.



ClinTex is a health technology company founded in 2017 that utilizes blockchain and machine learning to enhance the efficiency and cost-effectiveness of decentralized clinical trials. Their primary product, Clinical Trials Intelligence (CTi), is a suite of seven applications aimed at addressing various clinical trial pain points.

By leveraging blockchain technology, ClinTex ensures data integrity, security, and transparency, which are crucial in clinical trial processes. CTi's machine learning algorithms identify trends, predict outcomes, and optimize trial performance by analyzing data from various sources, enabling proactive issue resolution.

CTi offers a range of applications, including operational analytics, predictive recruitment, and risk-based monitoring, to streamline trial management, reduce patient attrition, and improve trial performance. Its real-time monitoring capabilities allow for better collaboration and informed decision-making among stakeholders.

In summary, ClinTex is revolutionizing decentralized clinical trials with its blockchain-based Clinical Trials Intelligence platform. By utilizing machine learning and blockchain technology, ClinTex aims to improve trial efficiency, reduce costs, and accelerate the development of new medical treatments.


Aural Analytics

Aural Analytics is a health technology company founded in 2015 that focuses on developing speech analytics as a digital biomarker for use in decentralized clinical trials. Their platform is designed to monitor and assess neurological, respiratory, and mental health conditions by analyzing patients' speech patterns.

The technology behind Aural Analytics is built on advanced algorithms and machine learning techniques that extract clinically relevant information from speech data. This includes aspects like pronunciation, fluency, and rhythm, which can provide insights into a patient's health status and disease progression.

One of the key advantages of Aural Analytics' platform is its ability to support multiple languages and work across various devices, making it adaptable and inclusive for clinical trials conducted in different countries and populations.

In decentralized clinical trials, the platform enables remote patient monitoring, reducing the need for in-person assessments. This not only improves patient convenience but also helps in increasing trial participation and retention rates. Additionally, it allows researchers to collect data continuously, providing real-time insights into treatment efficacy and safety.


Savvy Cooperative

Savvy Cooperative is a patient-owned platform founded in 2017, focusing on connecting patients and researchers to enable patient-centric decentralized clinical trials. By facilitating collaboration and data sharing between patients and researchers, Savvy Cooperative aims to improve the clinical trial process and accelerate medical advancements.

As a co-op, Savvy Cooperative empowers patients to become active partners in research, giving them a voice and an opportunity to share their experiences and insights. This approach ensures that trial designs are more patient-centered and reflective of the needs and preferences of the target population. Researchers can access a diverse pool of patient insights, leading to more effective trial outcomes and faster development of new treatments.

Savvy Cooperative offers various services, including patient recruitment, survey design, patient experience research, and user testing. By engaging patients directly, the platform helps address common challenges in clinical trials, such as recruitment and retention, while simultaneously promoting patient advocacy and involvement in the research process.



Teckro is a clinical trial technology company founded in 2015 in Ireland. Their digital platform aims to simplify and modernize clinical trial conduct by streamlining trial management and providing mobile access to essential information. Teckro's solution enhances efficiency, communication, and collaboration among sponsors, CROs, trial sites, investigators, and patients.

Key features include mobile access to trial information, real-time updates and notifications, secure communication, machine learning and AI for optimized search and retrieval of trial data, and integration with existing systems. With Teckro's mobile app, investigators and clinical trial staff can quickly access study protocols, inclusion and exclusion criteria, and other critical trial details. The platform's real-time updates help maintain consistency across trial sites and improve overall trial conduct. By leveraging machine learning and artificial intelligence, Teckro ensures efficient decision-making and improved patient care.



myClin is a Philadelphia-based company that offers a secure, collaborative platform for clinical trial management. Founded in 2008, myClin focuses on streamlining communication, document management, and compliance tracking among clinical research stakeholders, including sponsors, contract research organizations (CROs), clinical trial sites, and investigators.

myClin's platform addresses some of the key challenges in clinical trial management, such as information silos, fragmented communication, and inefficient document handling. By providing a centralized, user-friendly system, myClin makes it easier for clinical trial teams to work together and ensure that essential trial information is easily accessible and up-to-date.



Andaman7 is a Belgium-based health technology company founded in 2015. The company's primary focus is on creating a patient-centered platform for decentralized clinical trials, as well as for the management of personal health records. Their vision is to improve the overall healthcare ecosystem by facilitating collaboration between patients, researchers, and healthcare professionals while ensuring patient privacy and data security.

Andaman7's solution is a mobile application called A7 Health, which serves as a personal health record (PHR) for patients and a remote data collection tool for researchers. The app empowers patients by allowing them to collect, store, and manage their health data securely on their smartphones. Additionally, the platform enables patients to share their data with healthcare providers, researchers, and other authorized parties on a need-to-know basis, maintaining control over their information.


Reify Health

Reify Health is a healthcare technology company that focuses on accelerating clinical trials and improving the overall clinical research process. Founded in 2013 and headquartered in Boston, Massachusetts, Reify Health provides a cloud-based platform designed to streamline clinical trial management for sponsors, clinical research organizations (CROs), and clinical trial sites.

Reify Health's primary product is StudyTeam, a platform that offers an array of tools and features for clinical trial management, and it can be integrated with EHRs.

Share this:              

You may also be interested to read:



There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *